The Projection Analysis of NMR Chemical Shifts Reveals Extended EPAC Autoinhibition Determinants  by Selvaratnam, Rajeevan et al.
630 Biophysical Journal Volume 102 February 2012 630–639The Projection Analysis of NMR Chemical Shifts Reveals Extended EPAC
Autoinhibition DeterminantsRajeevan Selvaratnam,† Bryan VanSchouwen,† Federico Fogolari,§Mohammad T. Mazhab-Jafari,‡ Rahul Das,‡
and Giuseppe Melacini†‡*
†Department of Chemistry and Chemical Biology and ‡Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton,
Ontario, Canada; and §Department of Biomedical Science and Technology, University of Udine, Udine, ItalyABSTRACT EPAC is a cAMP-dependent guanine nucleotide exchange factor that serves as a prototypical molecular switch
for the regulation of essential cellular processes. Although EPAC activation by cAMP has been extensively investigated, the
mechanism of EPAC autoinhibition is still not fully understood. The steric clash between the side chains of two conserved resi-
dues, L273 and F300 in EPAC1, has been previously shown to oppose the inactive-to-active conformational transition in the
absence of cAMP. However, it has also been hypothesized that autoinhibition is assisted by entropic losses caused by quench-
ing of dynamics that occurs if the inactive-to-active transition takes place in the absence of cAMP. Here, we test this hypothesis
through the comparative NMR analysis of several EPAC1 mutants that target different allosteric sites of the cAMP-binding
domain (CBD). Using what to our knowledge is a novel projection analysis of NMR chemical shifts to probe the effect of the
mutations on the autoinhibition equilibrium of the CBD, we find that whenever the apo/active state is stabilized relative to the
apo/inactive state, dynamics are consistently quenched in a conserved loop (b2-b3) and helix (a5) of the CBD. Overall, our
results point to the presence of conserved and nondegenerate determinants of CBD autoinhibition that extends beyond the
originally proposed L273/F300 residue pair, suggesting that complete activation necessitates the simultaneous suppression
of multiple autoinhibitory mechanisms, which in turn confers added specificity for the cAMP allosteric effector.INTRODUCTIONThe exchange protein directly activated by cAMP (EPAC) is
a guanine nucleotide exchange factor for the small GTPases,
Rap1 and Rap2 (1–5), and is a key regulator of several phys-
iological responses with implications in chronic degenera-
tive inflammatory diseases (6). EPAC consists of an
N-terminal regulatory region (RR) and a C-terminal cata-
lytic region (CR). The RR of EPAC1 contains a single
cAMP binding domain (CBD), whereas the CR includes
a CDC25-homology domain (CDC25-HD), which binds
the Rap substrate (Fig. 1 a) (1–5).
The EPAC CBD is an archetype of other eukaryotic regu-
latory CBDs, such as those of Protein Kinase A (7–15) and
of the hyperpolarization-activated cyclic nucleotide-modu-
lated channels (16). The eukaryotic CBDs share a common
architecture with a b-subdomain of jellyroll b-sheets and
a noncontiguous a-subdomain. The latter includes an
N-terminal helical bundle (NTHB), a C-terminal helix
(a6), also known as the hinge helix, as well as a short helix
(a5) located between b6 and b7 in the phosphate binding
cassette (PBC), where cAMP docks (Fig. 1, b and d)
(8,11,12).
The orientation of a6 with respect to the PBC is
controlled by cAMP. In the absence of cAMP (i.e., apo-
state), the hinge helix is oriented away from the PBC
(Fig. 1, b–d), but upon cAMP binding the hinge helix rotatesSubmitted October 17, 2011, and accepted for publication December 13,
2011.
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0006-3495/12/02/0630/10 $2.00toward the PBC (Fig. 1, b–d). In the case of EPAC, the hinge
helix rotation is also coupled to a partial unfolding of the last
two turns of the a6 helix (Fig. 1, b–d) (3,17,18). These
cAMP-dependent changes in the a-subdomain are critical
for the control of autoinhibitory interactions (3,5,7–14,17–
20). Autoinhibition pertains to the mechanisms that prevent
the premature inactive-to-active transition in the absence
of the allosteric effector (i.e., autoinhibitory equilibria,
Fig. 1 a) (4,21). The maintenance of an autoinhibited state
is essential for eliciting cAMP dependence and preventing
constitutive activation, which can otherwise have drastic
effects on downstream signaling (4,6,21).
The cAMP-dependent hinge rotation has been previously
rationalized by the so-called hydrophobic hinge hypothesis,
which posits that a highly conserved contact between L273
in the PBC and F300 in a6 would lead to a steric clash if
the hinge reorientation toward the b-subdomain occurred
in the absence of cAMP (3–5). Such steric hindrance has
been suggested to be a key determinant of autoinhibition
and is alleviated by the repositioning of L273 caused by
cAMP binding (Fig. 1, b and c). Furthermore, it has been
hypothesized that an additional determinant of autoinhibi-
tion arises from entropic losses in the PBC a5 and in an
adjacent loop (b2-b3) caused by a reduction of dynamics
and tighter L273/F300 packing in the apo/active versus
apo/inactive states of the CBD (Fig. 1 a) (21). However,
this hypothesis has not been tested, as currently no experi-
mental data are available for the apo/active intermediate
due to its transient nature.doi: 10.1016/j.bpj.2011.12.030
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FIGURE 1 (a) Domain organization of EPAC1 and thermodynamic cycle
for the coupled cAMP binding and activation equilibria. The catalytic
region consists of the CDC25-homology domain (CDC25-HD), the Ras
exchange motif (REM), and the Ras association (RA) domain. The regula-
tory region contains the disheveled Egl-10 pleckstrin (DEP) domain and the
cyclic-nucleotide binding domain (CBD). (Gray) The CBD under study;
(black circle) the cAMP molecule. (Vertical black dashed line) Separation
between the RR and CR. (Encircling dashed line) Autoinhibitory equilib-
rium between the apo/inactive and apo/active states. (b) (Gray ribbon
diagram) The apo CBD structure, with the regions subject to major
cAMP-dependent changes (superimposed in green) with the corresponding
labels. (Black spheres) cAMP. (c) Expanded view of the L273/F300 pair in
the apo (gray) and holo (green) structures. (d) Contacts mediated by the
b2-b3 loop and the PBC. The PBD ID codes for the apo (gray) and holo
(green) structures are 2BYV and 3CF6, respectively.
Determinants of EPAC Autoinhibition 631Here, we test the hypothesis that the PBC a5 and b2-b3
loop dynamics are quenched in the apo/active conformation
relative to the apo/inactive state by investigating three single
point mutations that stabilize the transient apo/active state
by targeting the allosteric hot spots of the EPAC1 CBD
(i.e., G238A in the b2-b3 loop, Q270A in the a5 helix,
and E308A in the a6 hinge helix; Fig. 1 d). The effect of
each mutation on the active/inactive equilibrium of the
CBD was evaluated by NMR in the apo state, because the
autoinhibited state occurs in the absence of cAMP. Specifi-
cally, we used NMR to not only probe at atomic resolution
the changes in dynamics caused by the mutation, but also to
gauge how the mutation affects the position of the apo/inac-
tive versus apo/active equilibrium.
For this purpose, we propose a method based on 1H and
15N NMR chemical shifts, which are ideally suited to sense
changes in the position of the apo/inactive versus apo/active
equilibrium of EPAC in the fast exchange regime, mini-
mizing biases due to nearest-neighbor effects of the mutants.
This approach relies on the projection analysis (PA) of ppm
values and was validated using the L273W mutation, which
has been shown to stabilize the apo/inactive state (5). We
also complemented the NMR analyses with molecular
dynamics (MD) simulations, and our combined NMR andMD results indicate that whenever a mutant causes a stabili-
zation of the apo/active state, a quench in dynamics is con-
sistently observed for the a5 and b2-b3 loop regions. This
result is in agreement with the hypothesis that the autoinhi-
bited state is stabilized not only by the steric hindrance
between L273 and F300, but also by the a5/b2-b3 entropic
losses occurring when the inactive-to-active transition
ensues in the absence of cAMP. Overall, the combined anal-
ysis of the EPAC1 mutants presented here reveals, to our
knowledge, a novel model of EPAC autoinhibition, in which
the stabilization of the inactive versus active structures in
the absence of cAMP relies on a complex network of inter-
actions that extends well beyond the previously proposed
L273/F300 contact.MATERIALS AND METHODS
Purification of Wt and mutant EPAC1 constructs
Purification procedures used for both the wild-type (Wt) and mutant EPAC1
(GenBank No. AAC83381.1) constructs were as previously explained (20).
Briefly, cells of Escherichia coli strain BL-21 harboring plasmids encoding
EPAC1 constructs were grown in isotopically enriched media with 15NH4Cl
and 13C-labeled glucose. Cells were lysed as before and protein was
purified using the following chromatographic columns (GE Healthcare,
Waukesha, WI): Glutathione Sepharose 4B, HighTrap Q HP, and Superdex
75 16/60. Singly labeled 15N-acetylglycine (Sigma Aldrich, St. Louis, MO)
(0.5 mM) was added to the final concentrated protein sample (0.5 mM) as
a ppm-referencing compound.NMR measurements
All spectra were acquired at 306 K with an Avance 700-MHz spectrometer
(Bruker Daltonics, Billerica, MA) equipped with a 5 mm TCI CryoProbe
(Bruker BioSpin, Billerica, MA). Gradient- and sensitivity-enhanced
[15N-1H] heteronuclear single quantum coherence (HSQC) spectra with
256 (t1) and 1024 (t2) complex points and spectral widths of 31.82 parts-
per-million (ppm) and 14.06 ppm for the 15N and 1H dimensions, respec-
tively, were recorded with eight scans and a recycle delay of 1 s. Carrier
frequencies of the proton and nitrogen channels were centered on water
and the backbone amide region, respectively. All spectra were processed
with NMRPipe (22) employing linear prediction in the 15N dimension, and
a resolution-enhancing 60 shifted squared sine bell window function for
both dimensions. All 15N-1HHSQC crosspeaks were analyzed with the soft-
ware SPARKYusing Gaussian line-fitting (23). Assignments were obtained
using triple-resonance experiments, as previously explained (17,18).
The measured 13Ca, 13Cb, 13CO, 1H, and 15N chemical shifts were
utilized to derive order parameters by employing the RCI algorithm with
correct referencing (24) that reports on dynamic processes on a broad range
of timescales (25). Indeed, the trends captured by the RCI-based S2 values
are in agreement with previously measured 15N relaxation data for the apo-
Wt and cAMP-bound Wt states (17). In addition, the RCI-based order
parameters have the advantage of being measurable also for the critical
PBC region, which, in the apo-state, is subject to significant line-broad-
ening, compromising the signal/noise ratio of traditional 15N relaxation
experiments.MD simulation protocol
All simulations were executed using the EPAC2 fragment composed of
amino-acid residues 310–498 (corresponding to 175–363 in EPAC1h).Biophysical Journal 102(3) 630–639
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632 Selvaratnam et al.Mouse EPAC2 (GenBank No. AAD09132.1) was used for all MD simula-
tions, as this is the EPAC isoform for which experimental structures have
been determined by x-ray crystallography in the absence and presence of
the agonist Sp-cAMPS (3,4). It contains the functionally essential CBD,
which is highly homologous to the EPAC1h CBD (~81% sequence simi-
larity and ~69% sequence identity). Initial structures of the apo/inactive
and holo/active states were obtained from x-ray crystal structures with
PDB IDs 2BYV and 3CF6, respectively (3,4) by deleting all amino acids
other than residues 310–498 (i.e., 175–363 in EPAC1h) and all water mole-
cules from both structures. In addition, the bound Sp-cAMPS molecule was
replaced with the endogenous cAMP and an extra surface-bound Sp-
cAMPS molecule was deleted from the structure as it was found to be in
a crystal packing contact. For clarity, the corresponding EPAC1h amino-
acid numbering is used in the remaining part of the article, unless otherwise
specified. For further details, see the Supporting Material.co
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FIGURE 3 Effects of the L273W and G238A mutations on apo-Wt
EPAC1149-318. (a) The compounded chemical shift profile of the apo-mutant
relative to apo-Wt. (Dashed lines) The secondary structure of the apo form.
(Asterisks) Sites of mutation. (Highlighted shaded zones) Sites subject to
some of the most significant cAMP-dependent ppm changes for the apo-Wt
protein. (b) Fractional shift toward activation achieved by the mutation in
the absence of cAMP for residues with a compounded chemical shift
between the apo-Wt and holo-Wt greater than a cut-off value of
0.05 ppm. (c) Projection angle, which is also an indicator of the direction
of chemical shift movement along (positive values) or against (negative
values) the activation path (i.e., the vector B in Fig. 2).RESULTS
NMR chemical shift variations are sensitive reporters of
the position of the inactive versus active fast-exchanging
equilibrium of signaling proteins, such as EPAC (see
Fig. S1 in the Supporting Material) (20). However, the
commonly used compounded ppm changes, computed as
O((0.2DdN)
2þ(DdH)2) (9,13,14,17–19), report only on the
magnitude of the chemical shift variations caused by a muta-
tion (Fig. 2, dashed circles) and not on the direction in
which the given mutation affects the autoinhibitory equilib-
rium. For instance, Fig. 3 a shows the combined ppm
changes of apo-L273W versus apo-Wt EPAC1149-318. It
indicates that most of the regions subject to the largest
ppm shifts caused by the L273W mutation in the apo state
match quite well the sites displaying the most significant
cAMP-dependent ppm changes for the Wt protein (Fig. 3 a,
gray zones) (17,18,20). However, cAMP is an activator and
the L273W mutant is inactive (5). Thus the compounded
ppm changes provide an effective quantification of the
size of the ppm changes, but they are not sufficient to estab-
lish whether a mutation shifts the apo equilibrium towardFIGURE 2 Schematic illustration of the projection analysis of NMR
chemical shifts. (Open and solid circles) Apo and holo forms respectively,
as labeled in the figure. (Dark- and light-shaded) Wt and mutant peaks,
respectively. The compounded chemical shift between the apo-mutant
and the apo-Wt was calculated as the magnitude of vector A (i.e., jAj). Simi-
larly the compounded chemical shift between the cAMP-bound Wt and
apo-Wt was computed as jBj. (The modules of vectors A and B define the
radii of the dashed circles centered on the apo-Wt peak.)
Biophysical Journal 102(3) 630–639the inactive or the active state. To quantify both the size
and the direction of the perturbation caused by a mutation
on the autoinhibitory equilibrium, we introduce the projec-
tion analysis of NMR chemical shifts (Fig. 2). We will first
illustrate the projection analysis method and then validate
and apply it to the EPAC system.Projection analysis of NMR chemical shifts
The compounded chemical shift difference between the
apo-Wt and the apo-mutant was calculated as the magnitude
of vector A in Fig. 2 connecting the apo-Wt and apo-mutant
peaks and defined in the plane of the 1H and scaled 15N ppm
coordinates. The scaling factor of the 15N ppm values is 0.2
(20). Similarly, the compounded chemical-shift difference
between the apo-Wt and the cAMP-bound (holo) Wt is
computed as the magnitude of vector B in Fig. 2, which
represents the activation vector joining the apo/inactive to
the holo/active state. The projection of vector A onto B is
a measure of the shift along the activation vector caused
by a given mutation. To quantify the extent of activation
(or inactivation) achieved by a mutation in the absence of
Determinants of EPAC Autoinhibition 633cAMP, the fractional shift (X) is calculated as the ratio of the
component of vector A along vector B and the magnitude of
vector B (i.e., jBj):
X ¼ j
~Ajcos q
j~Bj ; (1)
where q is the angle between vectors A and B, as shown in
Fig. 2. Considering that
cosðqÞ ¼
~A ~B
j~Ajj~Bj; (2)
Eq. 1 is equivalent toX ¼
~A ~B

~B


2
: (3)
The fractional shift (X) is a scalar and is complemented byb
≥40
  20
  0X
β2-β3 
loop
α5 α6 
α4 
c d
≥30
  15
  0X
α4 
≥40
  20
  0X
β2-β3 
loop
α5 
α4 
a
≤-100
  -50
  0X
β2-β3 
loop
α5 α6 
α4 
L273W G238A
Q270A E308A
FIGURE 4 Structural map of the fractional chemical shift changes (X)
induced by mutations in the apo state for residues with jcos(q)j > 0.9, as
identified from Figs. 3 and 7. (a) L273W, (b) G238A, (c) Q270A, and (d)
E308A. There are a select few residues for which the fractional chemical
shift change is negative (or positive in the case of apo-L273W) when
jcos(q)j > 0.9. However, these residues cluster in the vicinity of the
mutation and are excluded as they are likely affected by nearest-neighbor
effects and not captured by the two-state model, as explained in Results.
(Star symbol, illustrated with sticks) The mutation site.the cos(q) value, which reports on the relative orientation of
vectors A and B. Thus, the projection analysis of NMR
chemical shifts results in two key residue-specific descrip-
tors of the perturbation caused by the mutation, i.e., the frac-
tional shift (X) and the cos(q) (Fig. 2). Only those residues
with jBj > 0.05 ppm were considered further in the projec-
tion analysis to filter out the fractional shifts (X) affected by
large experimental errors. Specifically, because jBj is used
to normalize the fractional shifts in Eq. 3, a small value of
jBj (e.g., jBj% 0.05 ppm) would result in an amplification
of the experimental error affecting the measurement of X. In
other words, the vector B used as a reference in the projec-
tion analysis must be reliable to result in meaningful frac-
tional activation values. Decreasing the jBj cut-off
threshold value would introduce more noise in the projec-
tion analysis, whereas increasing this threshold value would
filter out potentially informative residues, as illustrated in
Table S1 in the Supporting Material.
The fractional shift, X, is positive if the mutation shifts the
autoinhibition equilibrium toward the active state and nega-
tive otherwise. The absolute value of X approaches 0 if the
ppm variations caused by the mutation are negligible
compared to those caused by cAMP binding and/or if
vectors A and B are orthogonal (Fig. 2). When the mutation
and cAMP result in ppm changes of comparable magnitude
and direction, jXj ~ 1 (Fig. 2). The jcos(q)j values approach
unity (i.e., jcos(q)j ~1) when the effect of the mutation is
modeled exclusively based on the two-state active/inactive
equilibrium, irrespective of the magnitude of the muta-
tion-induced ppm changes. Whereas, jcos(q)j < 1 for resi-
dues that are more significantly affected by the mutation
through nearest-neighbor effects or other structural distor-
tions caused by the mutation and not fully modeled by a shift
in the two-state active/inactive equilibrium.
Consequently, the presence of more than two states in the
fast exchange regime would compromise the linear chemi-cal shift patterns (see Fig. S1) that are exploited by the
projection analysis (PA) method. This lack of linearity
would lead to jcos(q)j values below unity. Thus, only resi-
dues with jcos(q)j values approaching unity are suitable
reporters of the position of the two-state autoinhibitory equi-
librium through the fractional shift (X). The combined use of
cos(q) and X will be illustrated and validated by the applica-
tion of the PA method to the well-characterized L273W
inactive mutant.The EPAC autoinhibitory equilibrium is
sensitively probed through the projection
analysis of NMR chemical shifts: the L273W
mutant as a test case
As a first validation of the projection analysis of NMR
chemical shifts, we applied it to the apo-L273W versus
apo-Wt comparison (Fig. 3, b and c, black bars). The
L273W mutation has been shown to promote inactivation
(5,21) and therefore we expect a shift of the apo-EPAC
conformational equilibrium toward the inactive state. This
prediction is confirmed by the projection analysis in
Fig. 3, b and c (black bars), as the fractional shift (X) is
markedly negative for the residues with jcos(q)j approach-
ing unity (Fig. 3, b and c, and Fig. 4 a). Furthermore, the
projection analysis of L273W bound to cAMP indicates
that inactivation is preserved in the holo state (see
Fig. S2), in full agreement with the inability of cAMP to
activate the L273W mutant (5). Therefore, in contrast toBiophysical Journal 102(3) 630–639
634 Selvaratnam et al.compounded chemical shift profiles, the chemical shift
projection analysis provides an effective tool to establish
how a given mutation affects the inactive versus active equi-
libria of the EPAC CBD. In the following sections, the
projection analysis is utilized to assess the effect of point
mutations on the autoinhibitory apo-EPAC CBD equilibria.The projection analysis of the G238A mutant
reveals that the highly conserved Gly238 of the
b2-b3 loop contributes to autoinhibition
G238 of EPAC1 was chosen as a mutation site because this
residue is more conserved across CBDs than L273/F300
(11,12) and is indirectly involved in bridging contacts
between the PBC and the hinge helix (Fig. 1 d). To probe
the contribution of G238 to autoinhibition, we have purified
the G238A EPAC1149-318 mutant and have assigned and
analyzed the NMR chemical shifts (see Fig. S1). The com-
pounded chemical shifts for the apo G238A versus apo Wt
EPAC1149-318 comparison are shown in Fig. 3 a. Based on
Fig. 3 a, it is clear that the G238A mutation causes signifi-
cant long-range chemical shift perturbations that extend to
regions far removed from the site of the mutation (indicated
by asterisk). Remarkably, G238A affects all key allosteric
loci controlled by cAMP, i.e., the PBC, the hinge helix
(a6), and the adjacent a4 helix in the NTHB (Fig. 3 a), simi-
larly to L273W (Fig. 3 a, black bars). However, the projec-
tion analysis (Fig. 3, b and c) reveals a marked difference
between the L273W and G238A mutants in the apo-state.
Unlike apo-L273W, for apo-G238A, most of the residues
with jcos(q)j ~1 (Fig. 3 c) are characterized by strikingly
positive fractional shift (X) values (Fig. 4 b).
For instance, for the hinge helix (a6) as well as the adja-
cent a4 helix, the majority of fractional shifts are in the
~0.4–0.5 range, clearly indicating that the G238A mutation
causes a >40% shift of the conformational equilibria in the
apo EPAC1h CBD toward the active state, i.e., in the apo-
G238A mutant, the autoinhibition is partially, but signifi-
cantly, removed. Therefore the highly conserved G238 of
the b2-b3 loop is a key contributor to CBD autoinhibition,
exerting an inhibitory control on the allosteric sites of the
CBD, including the adjacent PBC and the distal C-terminal
hinge helix region (Fig. 4 b). In contrast, the G238A muta-
tion has relatively negligible effects on the holo/active state
of the CBD (Fig. S2, b and c), suggesting that, at the level of
the CBD, the G238A mutation results in more pronounced
perturbations on the autoinhibitory equilibria than on activa-
tion (Fig. 1 a). A possible explanation for the effect of G238
on the autoinhibitory equilibria is through the CH-p interac-
tion between the Ca of G238 and the guanidinium moiety
of a highly conserved arginine in the PBC, i.e., R279 in
EPAC1, which has been suggested to have coevolved with
G238 (12). To probe the effect of the G238A mutation on
the CH-p interaction between G238 and the R279 guanidi-
nium (Fig. 1 d), we performed MD simulations on the EPACBiophysical Journal 102(3) 630–639CBD in three states: the Wt apo, the mutant apo-G238A and
the Wt cAMP-bound forms.MD simulations indicate that the apo/active
mimicking mutation G238A leads to tighter G238/
R279 CH-p interactions and quenched dynamics
in the PBC/b2-b3 loop regions
The MD simulations were first validated by computing the
residue-specific a-helix probabilities (Fig. 5). We have
previously shown by NMR spectroscopy that the most
significant changes in secondary structure upon cAMP-
binding are an increase in the helicity of a5 in the PBC
and a concurrent helical unwinding in the C-terminal re-
gion of a6 in the hinge region (17,18). These experimental
observations are well reproduced by the simulated MD
trajectories (Fig. 5 a). Furthermore, because the projection
analysis of the NMR chemical shifts measured for apo
G238A indicates that this mutation causes a stabilization
of the active conformation, we expect that, if the MD simu-
lations are reliable, they should exhibit a stabilization of a5
and a C-terminal destabilization of a6 when Gly238 is
mutated to Ala in the apo form of EPAC. Fig. 5 a shows
that, indeed, the MD trajectory computed for the apo
G238A mutant displays the experimentally observed trend
for the variation in the helical profile of a5 and a6, indi-
cating that, despite the relatively brief 100-ns timescale of
the simulations, the MD trajectories capture at least qualita-
tively the trends observed experimentally through the
projection analysis of the chemical shifts of G238A. The
qualitative agreement between the MD simulations and
the NMR data suggest that the MD trajectories are a useful
tool to probe how the G238A mutation affects the CH-p
interactions between the conserved Gly and Arg residues
of the b2-b3 loop and PBC, respectively.
Fig. 5 b reports the MD-simulated time profiles for the
distances that define the CH-p G238/R279 interaction. The
G238/R279 distances for the Wt EPAC construct (Fig. 5 b,
gray and black traces) indicate that cAMP binding results
in a tightening of the CH-p interaction between these two
residues (17,18). Fig. 5 b reports also the G238/R279
distances simulated for the apo G238Amutant. Interestingly,
the G238A mutation results in a shortening of the 238/279
distances in the apo form that is remarkably similar to that
seen upon cAMP binding in the Wt construct (Fig. 5 b).
Thus, both the G238A mutation and cAMP-binding result
in a tighter CH-p 238/279 interaction. We therefore expect
that, similarly to cAMP binding, the G238Amutation should
lead to a quenching of dynamics for the PBC and b2-b3 loop
regions. This prediction is confirmed by the Procrustean
rotation analysis of the MD trajectories (see Fig. S3), which
indicates that the G238A substitution causes a net loss in the
relative PBC/b2-b3 loop dynamics of the apo form. ThisMD
result is in full agreement with the order parameters of
G238A (Fig. 6, a and b; see Fig. S4), indicating that this
CA/R279 CZ CA/R279 NE
CA/R279 NH1 CA/R279 NH2
Wt (Apo): G238A (Apo): Wt (+cAMP): 
Residue No.
α6
Hinge helix
a
b
α5
helix
270 280 290 300 310 320
0
2000
4000
6000
8000
10000
N
um
be
r o
f S
na
ps
ho
ts
FIGURE 5 Effect of the G238A mutation as modeled by MD simulations. (a) Secondary structure analyses over the course of the MD trajectories for the
apo-Wt, the holo-wt, and the apo-G238A constructs. The analysis is for the region spanning the a5 and a6 helices, which are known to be cAMP-dependent
(17–20). (b) Time profile for the contact distances between the Ca of residue 238 and the heavy atoms of the R279 guanidinium group. The color scheme is
indicated in panel a.
Determinants of EPAC Autoinhibition 635apo-state mutation causes a quenching in the ps-ns dynamics
of the PBC and b2-b3 regions.
Overall, the MD results suggest that G238 controls the
autoinhibitory equilibrium of EPAC through its interaction
with the guanidinium of R279, which in turn modulates
the dynamics and conformational entropy of the PBC and
b2-b3 loop regions. Based on this interpretation, G238Astabilizes the active conformation of the apo state by
reducing the entropic loss that occurs in the apo-inactive
to apo-active transition (Fig. 1 a). This conclusion high-
lights the importance of the conformational entropy in the
PBC and b2-b3 loop for the autoinhibitory equilibrium of
EPAC. However, it should be considered that the G238A
mutation not only shifts the autoinhibitory equilibrium ofBiophysical Journal 102(3) 630–639
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636 Selvaratnam et al.EPAC, but also causes severe nearest-neighbor perturba-
tions both at the site of the mutation and in the adjacent
PBC, as indicated by the large magnitude of the com-
pounded chemical shift changes (Fig. 3 a) and by the
reduced cos(q) values observed for these regions (Fig. 3 c).
Consequently, we conclude that, although the G238A muta-
tion is an excellent tool to evaluate the autoinhibitory role
of the b2-b3 loop, the autoinhibitory contribution of
entropic losses in the PBC and b2-b3 loop should be further
confirmed through other apo/active state-stabilizing muta-
tions that do not directly perturb the b2-b3 loop and are
therefore less invasive in this region. The E308A and
Q270A mutations are extremely useful in this respect
(Fig. 1 d).The E308A and Q270A EPAC1 mutants provide
a noninvasive glimpse of the apo/active metastate
The projection analysis of the chemical shifts of E308A and
Q270A EPAC1149-318 (Fig. 7, b and c) shows that both
mutants shift the apo conformational equilibria toward the
active state, because the majority of residues with jcos(q)j
~1 display positive fractional activation values in the
~0.2–~0.3 range (Fig. 7, b and c, and Fig. 4, c and d). In
this respect, the E308A and Q270A mutants mimic the
apo/active state, similarly to G238A, albeit to a smaller
extent. However, unlike G238A, the E308A and Q270A
mutants do not cause severe nearest-neighbor distortions
in the PBC and b2-b3 loop, as indicated by jcos(q)j valuesBiophysical Journal 102(3) 630–639close to unity for most of the residues in these regions
(Fig. 4, c and d). E308A and Q270A are therefore minimally
invasive apo/active-stabilizing mutants in the EPAC1149-318
construct, and as such they are ideally suited to test the
hypothesis that the PBC and b2-b3 loop dynamics are
quenched upon transition from the apo/inactive to apo/
active state, causing an entropic penalty that prevents
premature activation in the absence of cAMP, i.e., that
promotes autoinhibition.
To quantify the losses in conformational entropy occur-
ring in the apo/inactive to apo/active transition, we evalu-
ated the order parameters, S2 (26), for apo-E308A and
apo-Q270A (see Fig. S4) and compared them to the corre-
sponding apo-Wt values (Fig. 6, a and b). A remarkable
feature that emerges from Fig. 6 is that for both the b2-b3
loop and the PBC a5 helix, the order parameters measured
for the apo-Wt are consistently lower than those observed
for the apo-mutant samples with increased relative popula-
tions of the active conformation (i.e., G238A, E308A, and
Q270A). As shown in Fig. 6 b, the average b2-b3 and a5
S2 enhancement relative to apo-Wt is consistently positive
for both apo-mutants, similarly to G238A and to the Wt
cAMP-bound (holo) state. We therefore conclude that the
b2-b3 and PBC-a5 regions promote autoinhibition by
contributing a conformational entropy loss in the inactive-
to-active conformational transition.
Determinants of EPAC Autoinhibition 637DISCUSSION
The autoinhibition determinants of EPAC extend
beyond the L273/F300 pair of the hydrophobic
hinge and include the b2-b3 loop and the a5 helix
The mechanism of autoinhibition in EPAC has been previ-
ously rationalized in terms of the hydrophobic hinge
hypothesis (4,5), whereby the reorientation of the hinge
helix toward the b-subdomain required for activation is
prevented by a steric clash between the L273 in a5 and
F300 in a6 (Fig. 1 c). Our NMR data support this mecha-
nism, as the projection analysis of the chemical shifts of
L273W shows that this bulky mutant shifts the apo confor-
mational equilibrium toward the inactive state. However,
the NMR investigation of the other mutations included in
this study clearly reveals that the L273/F300 steric
hindrance is not the only determinant of EPAC autoinhibi-
tion. Several other structural elements of the CBD of EPAC
contribute to the control of the inactive-versus-active
conformational equilibrium of the CBD in the absence of
cAMP. Here we have identified two such elements, i.e.,
the a5 in the PBC and the b2-b3 loop. The b2-b3 loop
has been previously shown to play a key role in the
cAMP-dependent activation of EPAC (17,18,20,21), but
its contribution to autoinhibition (i.e., to the selective stabi-
lization of the apo/inactive versus apo/active state) was not
anticipated before, to our knowledge. In the following
sections we discuss the mechanism utilized by these struc-
tural moieties to control the position of the autoinhibitory
equilibrium of EPAC.Entropic control of autoinhibition by a5 and the
b2-b3 loop
The comparative analysis of the G238A, Q270A, and
E308A mutants indicates that whenever the apo/active state
is stabilized relative to the apo/inactive state (Fig. 1 a), the
dynamics of the b2-b3 and a5 regions is consistently
reduced. This result fully supports the hypothesis that the
b2-b3 loop and the a5 in the PBC help control the position
of the apo/inactive versus apo/active equilibrium by
imposing an unfavorable entropic loss as their ps-ns
dynamics are quenched in the inactive-to-active conforma-
tional transition. A similar quenching of dynamics was
previously reported for the b2-b3 loop and the a5 helix
upon cAMP binding to Wt EPAC1 as measured by 15N
relaxation measurements (17). However, in the absence of
cAMP, this entropic penalty does not appear to be fully
compensated by the enthalpic gain resulting from the
tighter G238/R279 Ca-p and L273/F300 van der Waals
contacts in the apo/active versus apo/inactive structures.
This conclusion highlights how flexible regions in the
apo form can be a critical molecular determinant of
autoinhibition.The investigated determinants of autoinhibition
in EPAC CBD are nondegenerate and lead to
enhanced specificity in the ligand-dependent
activation
The main goal of this work was to identify key determinants
of autoinhibition in the cAMP-binding domain (CBD) of
EPAC, which serves also as a model system for other eu-
karyotic CBDs. The isolated CBD model used here (i.e.,
EPAC1149-318) is ideally suited for this purpose. In addition,
we anticipate that, if the NMR data on the CBD are func-
tionally relevant, a shift toward activation in the autoinhibi-
tory equilibrium of the apo CBD should result in decreased
AC50 and increased kmax values (27) as measured from
bioassays (see Fig. S5). This prediction is confirmed not
only in the extreme case of L273W as discussed above
(5), but also in the case of Q270A and E308A, for which
published AC50 and kmax values are available (see Table
S2) (27), suggesting that, at least on a qualitative basis,
the NMR data on the isolated CBD bear some functional
significance. However, a quantitative correlation between
the NMR and the bioassay data (i.e., AC50 and kmax values)
is not warranted at this stage, because the construct used in
our NMR studies is a fragment of the multidomain EPAC
proteins typically required for functional assays. These
longer constructs include additional autoinhibitory elements
that involve other domains. For instance, the so-called ionic
latch is a set of salt bridges between the regulatory and cata-
lytic regions of EPAC, which selectively stabilizes the
closed inactive topology of EPAC.
We therefore expect that the correlation between the NMR
results on the isolated CBD and the bioassay data to be only
qualitative (seeTableS2).Despite these limitations, a striking
feature of autoinhibition emerging from this NMR muta-
tional study is that the suppression of a single autoinhibition
determinant, among those investigated here, is insufficient to
elicit a complete shift toward activation—i.e., no single
mutation out of those tested is able to completely mimic
the activation obtained at saturating cAMP concentrations.
This observation suggests that it is necessary to simulta-
neously suppress multiple autoinhibitory determinants to
obtain a complete shift toward the active state. In this respect,
the different structural elements of the CBD involved in auto-
inhibition (i.e., a5, b2-b3 loop, and a6) are nondegenerate
and we propose that such lack of degeneracy in the autoinhi-
bition mechanism of EPAC confers added specificity toward
cAMP. Overall, the requirement that multiple autoinhibitory
determinants must be simultaneously and collectively sup-
pressed builds into the CBD a molecular switch with
increased specificity toward the cAMP ligand.CONCLUDING REMARKS
The mutations utilized in this study suggest that the previ-
ously proposed hydrophobic hinge hypothesis based onBiophysical Journal 102(3) 630–639
638 Selvaratnam et al.the L273/F300 steric clash is not sufficient alone to account
for all the molecular determinants of EPAC autoinhibition.
First, several other highly conserved motifs within the
CBD contribute to autoinhibition, including the b2-b3
loop and the a5 helix. Second, these conserved structural
elements fine-tune the autoinhibitory equilibrium of EPAC
for optimal cAMP sensitivity not only through steric and
van der Waals interactions, as previously proposed, but
also through entropic losses arising from regions that are
more dynamic in the apo/inactive state relative to the apo/
active state. Third, the multiple autoinhibitory determinants
identified here appear to be nondegenerate with respect to
the complete activation of EPAC, suggesting that their
collective suppression is required for full EPAC activity.
Such nondegeneracy provides an effective means to enhance
the specificity of the allosteric effectors that act on the EPAC
molecular switch. Fourth, we anticipate that the concepts
and methods illustrated here will be useful also for other
systems. For instance, the presumed novel projection anal-
ysis (PA) proposed here will likely be useful in evaluating
how mutations modulate the position of conformational
equilibria for domains that function as allosteric sensors in
the regulation of signaling pathways (28–30).SUPPORTING MATERIAL
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